New oral drug could help short children grow taller
NCT ID NCT07264595
First seen Jan 06, 2026 · Last updated Apr 29, 2026 · Updated 17 times
Summary
This study tests a new oral medicine (GS3-007a) for children with growth hormone deficiency who have not yet received any growth-promoting drugs. In the first part, different doses are compared to a placebo over 14 days to find a safe dose. In the second part, the chosen dose is compared to an approved treatment for 52 weeks, with a long-term follow-up. The goal is to see if the new treatment can safely improve growth.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC GROWTH HORMONE DEFICIENCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, 430000, China
Conditions
Explore the condition pages connected to this study.